Following the Phase II faceoff between two of Scancell’s lead melanoma immunotherapy candidates, the biotech has selected ...

A groundbreaking study has revealed that white sugar doesn’t just feed the bacteria in your gut – it rewires them.

Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel immunomodulation platform designed to restore innate immune function, is excited ...

Diakonos Oncology has dosed the first subject in its Phase II trial of investigational patient-derived double-loaded dendritic cell therapy, DOC1021, for treating a highly aggressive brain tumour, ...

A new dual vaccine for COVID-19 and flu shows strong immune responses and good safety in adults over 50, offering a potential ...

SCOPE trial of SCIB1/iSCIB1+ plus standard of care shows excellent results encompassing efficacy, durability, immune responses and safety ...

Radiation therapy, once thought of mainly as a local cancer treatment, is now showing power to awaken the immune system in surprising ways. Researchers discovered that combining radiation with ...

By sparking the immune system into action, radiation therapy makes certain tumors that resist immunotherapy susceptible to ...

Scancell has linked iSCIB1+ to a 69% response rate in advanced melanoma, lead | Scancell has linked iSCIB1+ to a 69% response ...

Ukrainian activists are calling for more protests of a law they say weakens the country’s anti-corruption bodies.

Dr. Iwasaki is internationally recognized for her groundbreaking research on viral pathogenesis, human immunobiology, and post-viral chronic conditions, including Long COVID and COVID-19 ...

Patients with skin cancer who were fed a high-fiber diet showed better response rates to treatment and longer event-free ...